首页 > 最新文献

Voprosy meditsinskoi khimii最新文献

英文 中文
[Levels of autoantibodies to glutamate receptors and immunological blood parameters in patients with epilepsy]. [癫痫患者谷氨酸受体自身抗体水平和免疫血液参数]。
Pub Date : 2002-07-01
V G Bazarova, O K Granstrem, S A Dambinova

The role of glutamate receptors in the brain spiking activity was evaluated. The electroencephalographic (EEG) spiking activity was monitored and autoreactive antibodies (aAbs) to subunits of glutamate receptors were assessed in the blood serum of epileptic and ischemic stroke patients. We showed that the level of GluR autoantibodies in blood serum of patients correlates to the intensity of the brain paroxysmal activity. These data confirm our previous observations. The level of GluR1 aABs has been proposed as a specific biomarker typical for epilepsy. This approach could be recommended as an additional criterion for diagnostic of nervous diseases such as epilepsy and ischemic stroke.

评估了谷氨酸受体在大脑尖峰活动中的作用。测定癫痫和缺血性脑卒中患者血清中谷氨酸受体亚基自身反应性抗体(aAbs)和脑电图(EEG)尖峰活动。我们发现患者血清中GluR自身抗体的水平与大脑发作活动的强度相关。这些数据证实了我们以前的观察。GluR1抗体水平已被认为是癫痫的一种特异性生物标志物。这种方法可以推荐作为诊断神经疾病如癫痫和缺血性中风的附加标准。
{"title":"[Levels of autoantibodies to glutamate receptors and immunological blood parameters in patients with epilepsy].","authors":"V G Bazarova,&nbsp;O K Granstrem,&nbsp;S A Dambinova","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The role of glutamate receptors in the brain spiking activity was evaluated. The electroencephalographic (EEG) spiking activity was monitored and autoreactive antibodies (aAbs) to subunits of glutamate receptors were assessed in the blood serum of epileptic and ischemic stroke patients. We showed that the level of GluR autoantibodies in blood serum of patients correlates to the intensity of the brain paroxysmal activity. These data confirm our previous observations. The level of GluR1 aABs has been proposed as a specific biomarker typical for epilepsy. This approach could be recommended as an additional criterion for diagnostic of nervous diseases such as epilepsy and ischemic stroke.</p>","PeriodicalId":23535,"journal":{"name":"Voprosy meditsinskoi khimii","volume":"48 4","pages":"381-7"},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22177150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Correction of lipid metabolism in rabbits with experimental cholelithiasis]. [对实验性胆石症家兔脂质代谢的纠正]。
Pub Date : 2002-07-01
Iu A Bogdarin, D V Kozlov

The effect of 16-20% medicinal preparation "Equalen" on some parameters of lipid metabolism in female rabbits with cholelithiasis induced by 40% clamp of common bile duct was investigated. The total course of Equalen administration for 90-120 days included daily oral administration of Equalen for 7 days followed by 3-4 day interval. The optimal dose was 1.5 ml per day (the effective range of doses varied from 1.2 to 2.0 ml). Such treatment resulted in disappearance of large and medium sized cholesterol formations from gallbladder, normalization of lipid metabolism in organs of hepatoenteric system and lipid composition of bile.

研究了16-20%药物制剂“相等”对40%胆总管夹持所致雌性胆结石兔脂质代谢指标的影响。本品给药90 ~ 120天的总疗程包括每日口服本品7天,间隔3 ~ 4天。最佳剂量为每天1.5毫升(有效剂量范围为1.2至2.0毫升)。这种治疗使胆囊中、大尺寸胆固醇的形成消失,肝肠系统各器官脂质代谢和胆汁脂质组成正常化。
{"title":"[Correction of lipid metabolism in rabbits with experimental cholelithiasis].","authors":"Iu A Bogdarin,&nbsp;D V Kozlov","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The effect of 16-20% medicinal preparation \"Equalen\" on some parameters of lipid metabolism in female rabbits with cholelithiasis induced by 40% clamp of common bile duct was investigated. The total course of Equalen administration for 90-120 days included daily oral administration of Equalen for 7 days followed by 3-4 day interval. The optimal dose was 1.5 ml per day (the effective range of doses varied from 1.2 to 2.0 ml). Such treatment resulted in disappearance of large and medium sized cholesterol formations from gallbladder, normalization of lipid metabolism in organs of hepatoenteric system and lipid composition of bile.</p>","PeriodicalId":23535,"journal":{"name":"Voprosy meditsinskoi khimii","volume":"48 4","pages":"368-72"},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22177148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Mitochondrial diseases--a new branch of the modern medicine]. [线粒体疾病——现代医学的一个新分支]。
Pub Date : 2002-07-01
P P Zagoskin, E M Khvatova

The review highlights current aspects of a large group of diseases the main pathogenetic element of which is an inherited or acquired disturbance of gene expression of nuclear or mitochondrial genome encoding mitochondrial proteins. The recent data on mutant genetic loci specific to the most wide spread mitochondrial diseases are considered. The steps of pathogenesis, include the mutations of nuclear or mitochondrial genes, disturbances of mitochondrial protein synthesis, dissipation of proton membrane potential, opening of a permeability transition pore, releasing of procaspases, cytochrome c, and other proapoptotic molecules, and finally chromatin fragmentation and apoptotic cell death. We discuss the possible reasons of polysymptomatic character and different variants of mitochondrial disease manifestations on the basis of the phenomenon of mitochondrial DNA heteroplasmy and metabolic compensation of the genetic defects. Modern biochemical methods of a mitochondrial disease diagnostics: (PCR-amplification, polarographic research of mitochondrial respiration and oxidative phosphorylation, analysis and monitoring of metabolites in biological liquids) are characterized. The basic principles and perspectives of the treatment of mitochondrial diseases, (gene therapy, correction of metabolic disorders, application of antioxidants and neuropeptides) are described.

这篇综述强调了目前一大类疾病的一些方面,这些疾病的主要致病因素是编码线粒体蛋白的核或线粒体基因组基因表达的遗传或获得性紊乱。考虑到最广泛传播的线粒体疾病的突变基因位点的最新数据。其发病步骤包括核或线粒体基因突变,线粒体蛋白合成紊乱,质子膜电位耗散,通透性过渡孔打开,原aspase、细胞色素c等促凋亡分子释放,最终染色质断裂,凋亡细胞死亡。本文从线粒体DNA异质性和遗传缺陷的代谢代偿等方面探讨了线粒体疾病多症状特征和不同变异表现的可能原因。线粒体疾病诊断的现代生化方法(pcr扩增,线粒体呼吸和氧化磷酸化的极谱研究,生物液体中代谢物的分析和监测)的特点。介绍了线粒体疾病治疗的基本原理和前景(基因治疗、代谢紊乱的纠正、抗氧化剂和神经肽的应用)。
{"title":"[Mitochondrial diseases--a new branch of the modern medicine].","authors":"P P Zagoskin,&nbsp;E M Khvatova","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The review highlights current aspects of a large group of diseases the main pathogenetic element of which is an inherited or acquired disturbance of gene expression of nuclear or mitochondrial genome encoding mitochondrial proteins. The recent data on mutant genetic loci specific to the most wide spread mitochondrial diseases are considered. The steps of pathogenesis, include the mutations of nuclear or mitochondrial genes, disturbances of mitochondrial protein synthesis, dissipation of proton membrane potential, opening of a permeability transition pore, releasing of procaspases, cytochrome c, and other proapoptotic molecules, and finally chromatin fragmentation and apoptotic cell death. We discuss the possible reasons of polysymptomatic character and different variants of mitochondrial disease manifestations on the basis of the phenomenon of mitochondrial DNA heteroplasmy and metabolic compensation of the genetic defects. Modern biochemical methods of a mitochondrial disease diagnostics: (PCR-amplification, polarographic research of mitochondrial respiration and oxidative phosphorylation, analysis and monitoring of metabolites in biological liquids) are characterized. The basic principles and perspectives of the treatment of mitochondrial diseases, (gene therapy, correction of metabolic disorders, application of antioxidants and neuropeptides) are described.</p>","PeriodicalId":23535,"journal":{"name":"Voprosy meditsinskoi khimii","volume":"48 4","pages":"321-36"},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22177333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Evaluation of preservation and the collagen structure state in the mummy tissues]. [木乃伊组织中胶原蛋白结构状态及保存评价]。
Pub Date : 2002-07-01
Iu A Romakov, V A Bykov, G A Rebrova, V K Vasilevskiĭ, So San Ho, L B Rebrov

The content and state of collagen in skin, muscle and bone of 2500-year-old Altai mummies were studied. Collagen is the predominant protein in studied tissues of the mummies. High degree of the resistance of collagen to the effect of various proteases (collagenase, pronase, pepsin) and to alkline and acidic hydrolysis suggests on the considerable chemical modification of tissue collagen structures of the mummy. The possibility of increased collagen cross-linkages in tissues of the mummies during long-term storage and of nonenzymatic glycosylation of collagen leading to the formation an Amadori products and other modified structures are discussed.

研究了2500年前阿尔泰木乃伊皮肤、肌肉和骨骼中胶原蛋白的含量和状态。胶原蛋白是木乃伊组织中主要的蛋白质。胶原蛋白对各种蛋白酶(胶原酶、蛋白酶、胃蛋白酶)的作用以及碱性和酸性水解的高度抵抗表明,木乃伊的组织胶原蛋白结构受到了相当大的化学修饰。讨论了长期储存期间木乃伊组织中胶原交联增加的可能性,以及胶原的非酶糖基化导致Amadori产品和其他修饰结构的形成。
{"title":"[Evaluation of preservation and the collagen structure state in the mummy tissues].","authors":"Iu A Romakov,&nbsp;V A Bykov,&nbsp;G A Rebrova,&nbsp;V K Vasilevskiĭ,&nbsp;So San Ho,&nbsp;L B Rebrov","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The content and state of collagen in skin, muscle and bone of 2500-year-old Altai mummies were studied. Collagen is the predominant protein in studied tissues of the mummies. High degree of the resistance of collagen to the effect of various proteases (collagenase, pronase, pepsin) and to alkline and acidic hydrolysis suggests on the considerable chemical modification of tissue collagen structures of the mummy. The possibility of increased collagen cross-linkages in tissues of the mummies during long-term storage and of nonenzymatic glycosylation of collagen leading to the formation an Amadori products and other modified structures are discussed.</p>","PeriodicalId":23535,"journal":{"name":"Voprosy meditsinskoi khimii","volume":"48 4","pages":"357-60"},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22177145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[All-Russian Conference "Problems of Medicinal Enzymology. Modern Technologies in Laboratory Diagnosis in the New Century". Moscow. May, 2002. Abstracts]. 全俄会议“药物酶学问题”新世纪实验室诊断的现代技术”。莫斯科。2002年5月。摘要]。
Pub Date : 2002-07-01
{"title":"[All-Russian Conference \"Problems of Medicinal Enzymology. Modern Technologies in Laboratory Diagnosis in the New Century\". Moscow. May, 2002. Abstracts].","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":23535,"journal":{"name":"Voprosy meditsinskoi khimii","volume":"48 4","pages":"395-411"},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22330525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Genetic heterogeneity of cytochrome CYP51 in clinical strains of Mycobacterium tuberculosis]. [临床结核分枝杆菌菌株细胞色素CYP51的遗传异质性]。
Pub Date : 2002-07-01
A S Shavkunov, V N Lazarev, L N Chernausova, A V Kuz'min, V M Govorun

Information on the complete genome sequences of a number of organisms available recently offers essentially new opportunities for the development of new, highly effective antimicrobial compounds. In particular, the search for new effective antituberculosis drugs remains an important problem, due to the recent increase of number of patients suffering with tuberculosis. In this respect considerable attention is paid to the cyp51-like gene Rv0764c encoding sterol-14 alpha-demethylase belonging to the cytochrome P450 superfamily, which has been discovered by computer analysis of the Mycobacterium tuberculosis genome sequence. We have screened 64 clinical isolates of M. tuberculosis for functionally relevant mutations in the coding sequence of the gene encoding Cyp 51-demethylase by single-strand conformation polymorphism analysis (SSCP) and sequencing of PCR-amplified gene fragments. Structural analysis of the gene in the isolates revealed no mutations leading to amino acid substitutions in the corresponding protein. 10 isolates had a silent nucleotide substitution 114 GCT-->GCC. Computer analysis of cyp51 sequence of the CDC1551 strain also revealed a similar nucleotide substitution, which has not been mentioned previously. The data obtained demonstrate that the sequence of the gene is highly conserved, supporting the advisability of M. tuberculosis Cyp51 protein to be considered as a molecular target for new antitubercular drugs. The SNP found in the gene coding sequence may be employed in the studies of M. tuberculosis population genetics.

最近获得的关于许多生物体全基因组序列的信息为开发新的高效抗菌化合物提供了新的机会。特别是,寻找新的有效的抗结核药物仍然是一个重要的问题,由于近年来结核病患者人数的增加。在这方面,人们相当重视编码甾醇-14 α -去甲基化酶的cyp51样基因Rv0764c,该基因属于细胞色素P450超家族,是通过计算机分析结核分枝杆菌基因组序列发现的。我们通过单链构象多态性分析(SSCP)和pcr扩增的基因片段测序,筛选了64株结核分枝杆菌编码Cyp 51-去甲基化酶基因编码序列的功能相关突变。该基因在分离株中的结构分析显示,没有导致相应蛋白质氨基酸取代的突变。10株分离株有沉默核苷酸取代114 GCT- >GCC。对CDC1551菌株cyp51序列的计算机分析也发现了类似的核苷酸替换,这在以前没有提到过。所获得的数据表明,该基因的序列高度保守,支持结核分枝杆菌Cyp51蛋白作为抗结核新药分子靶点的可行性。在基因编码序列中发现的SNP可用于结核分枝杆菌群体遗传学的研究。
{"title":"[Genetic heterogeneity of cytochrome CYP51 in clinical strains of Mycobacterium tuberculosis].","authors":"A S Shavkunov,&nbsp;V N Lazarev,&nbsp;L N Chernausova,&nbsp;A V Kuz'min,&nbsp;V M Govorun","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Information on the complete genome sequences of a number of organisms available recently offers essentially new opportunities for the development of new, highly effective antimicrobial compounds. In particular, the search for new effective antituberculosis drugs remains an important problem, due to the recent increase of number of patients suffering with tuberculosis. In this respect considerable attention is paid to the cyp51-like gene Rv0764c encoding sterol-14 alpha-demethylase belonging to the cytochrome P450 superfamily, which has been discovered by computer analysis of the Mycobacterium tuberculosis genome sequence. We have screened 64 clinical isolates of M. tuberculosis for functionally relevant mutations in the coding sequence of the gene encoding Cyp 51-demethylase by single-strand conformation polymorphism analysis (SSCP) and sequencing of PCR-amplified gene fragments. Structural analysis of the gene in the isolates revealed no mutations leading to amino acid substitutions in the corresponding protein. 10 isolates had a silent nucleotide substitution 114 GCT-->GCC. Computer analysis of cyp51 sequence of the CDC1551 strain also revealed a similar nucleotide substitution, which has not been mentioned previously. The data obtained demonstrate that the sequence of the gene is highly conserved, supporting the advisability of M. tuberculosis Cyp51 protein to be considered as a molecular target for new antitubercular drugs. The SNP found in the gene coding sequence may be employed in the studies of M. tuberculosis population genetics.</p>","PeriodicalId":23535,"journal":{"name":"Voprosy meditsinskoi khimii","volume":"48 4","pages":"361-7"},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22177146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Myeloperoxidase in the human placenta at preterm labor]. [早产儿人胎盘中的髓过氧化物酶]。
Pub Date : 2002-07-01
V M Prokopenko, G M Aleshina, E V Frolova, V V Anan'eva, V N Kokriakov, A V Arutiunian

In the present study the level of myeloperoxidase in the human placenta at premature was investigated. Mycloperoxidase content did not depend on its localization in placenta and decreased at premature labour. It is suggested that the decrease in the myeloperoxidase content in placenta results in the weakening of antimicrobial barrier in the system mother-placenta-fetus and plays an important role in pathogenesis of premature delivery at later term.

本研究对早产儿人胎盘髓过氧化物酶水平进行了研究。霉菌过氧化物酶的含量不依赖于其在胎盘中的定位,并在早产时降低。提示胎盘髓过氧化物酶含量降低导致母体-胎盘-胎儿系统抗菌屏障减弱,在晚期早产发病机制中起重要作用。
{"title":"[Myeloperoxidase in the human placenta at preterm labor].","authors":"V M Prokopenko,&nbsp;G M Aleshina,&nbsp;E V Frolova,&nbsp;V V Anan'eva,&nbsp;V N Kokriakov,&nbsp;A V Arutiunian","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In the present study the level of myeloperoxidase in the human placenta at premature was investigated. Mycloperoxidase content did not depend on its localization in placenta and decreased at premature labour. It is suggested that the decrease in the myeloperoxidase content in placenta results in the weakening of antimicrobial barrier in the system mother-placenta-fetus and plays an important role in pathogenesis of premature delivery at later term.</p>","PeriodicalId":23535,"journal":{"name":"Voprosy meditsinskoi khimii","volume":"48 4","pages":"378-80"},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22177149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Regulation of ceruloplasmin activity in oncogynecological diseases]. [妇科肿瘤中铜蓝蛋白活性的调控]。
Pub Date : 2002-07-01
Iu N Gusarova, E V Stepanova, E O Landesman, O V Koroleva, T P Vavilova, O V Makarov, V N Kosetskiĭ

Serum ceruloplasmih (CP) and anti-CP antibody levels were studied by the oxidase method in 18 healthy women and in 86 women with gynecological tumors. The results demonstrate that: 1) Serum CP concentrations increased in endometrial and ovarian cancer, in benign ovarian tumors and to a lesser extent in mioma of uterus. 2) Serum CP antibodies were found out in both benign tumors and cancer cases. 3) There was positive linear correlation between serum levels of CP and anti-CP-antibodies in endometrial and ovarian cancers, and in benign ovarian tumors.

采用氧化酶法对18例健康妇女和86例妇科肿瘤患者血清铜质粒(CP)及抗CP抗体水平进行了研究。结果表明:1)血清CP浓度在子宫内膜癌、卵巢癌、良性卵巢肿瘤和子宫mioma中均有较低的升高。2)在良性肿瘤和恶性肿瘤中均可检测到血清CP抗体。3)子宫内膜癌、卵巢癌及卵巢良性肿瘤患者血清CP水平与抗CP抗体呈线性正相关。
{"title":"[Regulation of ceruloplasmin activity in oncogynecological diseases].","authors":"Iu N Gusarova,&nbsp;E V Stepanova,&nbsp;E O Landesman,&nbsp;O V Koroleva,&nbsp;T P Vavilova,&nbsp;O V Makarov,&nbsp;V N Kosetskiĭ","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Serum ceruloplasmih (CP) and anti-CP antibody levels were studied by the oxidase method in 18 healthy women and in 86 women with gynecological tumors. The results demonstrate that: 1) Serum CP concentrations increased in endometrial and ovarian cancer, in benign ovarian tumors and to a lesser extent in mioma of uterus. 2) Serum CP antibodies were found out in both benign tumors and cancer cases. 3) There was positive linear correlation between serum levels of CP and anti-CP-antibodies in endometrial and ovarian cancers, and in benign ovarian tumors.</p>","PeriodicalId":23535,"journal":{"name":"Voprosy meditsinskoi khimii","volume":"48 4","pages":"388-93"},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22177152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A drop of mink complement kills a mouse]. [一滴水貂补剂杀死一只老鼠]。
Pub Date : 2002-07-01
Z P Belkin, L V Kozlov, S S Andina, A A Mishin, V A Guzova, V L D'iakov

The phenomenon of fast death of mice after parenteral administration of mink serum was explained by high activity of mink complement in particular by unusually high activity of its alternative pathway of activation. The presence of antibodies to mouse erythrocytes in mink serum was necessary precondition for their lysis under action of mink complement by classical and alternative pathways. However, removal of these antibodies resulting in cancellation of hemolysis did not effect toxicity of mink serum for nice in vivo. Partial decomplementization of mink serum zymosan completely prevented death of animals.

水貂补体的高活性,特别是其替代激活途径的异常高活性可以解释水貂血清外注射后小鼠快速死亡的现象。水貂血清中小鼠红细胞抗体的存在是其在水貂补体作用下通过经典途径和替代途径裂解的必要前提。然而,去除这些抗体导致溶血功能的取消并不影响水貂血清对nice的体内毒性。水貂血清酶酶的部分失补体完全防止了动物的死亡。
{"title":"[A drop of mink complement kills a mouse].","authors":"Z P Belkin,&nbsp;L V Kozlov,&nbsp;S S Andina,&nbsp;A A Mishin,&nbsp;V A Guzova,&nbsp;V L D'iakov","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The phenomenon of fast death of mice after parenteral administration of mink serum was explained by high activity of mink complement in particular by unusually high activity of its alternative pathway of activation. The presence of antibodies to mouse erythrocytes in mink serum was necessary precondition for their lysis under action of mink complement by classical and alternative pathways. However, removal of these antibodies resulting in cancellation of hemolysis did not effect toxicity of mink serum for nice in vivo. Partial decomplementization of mink serum zymosan completely prevented death of animals.</p>","PeriodicalId":23535,"journal":{"name":"Voprosy meditsinskoi khimii","volume":"48 4","pages":"373-7"},"PeriodicalIF":0.0,"publicationDate":"2002-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22177147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Effect of pyruvate, threonine, and phosphoethanolamine on acetaldehyde metabolism in rats with toxic liver injury]. [丙酮酸、苏氨酸和磷酸乙醇胺对中毒性肝损伤大鼠乙醛代谢的影响]。
Pub Date : 2002-05-01
P S Pron'ko, V I Satanovskaia, B I Gorenshteĭn, A B Kuz'mich, T N Pyzhik

Pyruvate dehydrogenase, threonine aldolase and phosphoethanolamine lyase can produce acetaldehyde during normal metabolism. We studied the effect of loading with the substrates of these enzymes (pyruvate, 500 mg/kg, i.p., threonine 500 mg/kg, i.p., and phosphoethanolamine, 230 mg/kg, i.p.) on the blood concentrations of endogenous acetaldehyde and ethanol and the activities of enzymes producing and oxidizing acetaldehyde in the liver of normal rats and rats with liver injury provoked by chronic carbon tetrachloride (CCl4) treatment (0.2 ml i.p. per rat, 2 times a week during 4 weeks). Blood was collected before the treatment and then 30 min and 1 h following the administration of the substrates to intact and CCl4-treated rats. Endogenous acetaldehyde and ethanol were determined by headspace GC. The CCl4 treatment resulted in decreased liver alcohol dehydrogenase and aldehyde dehydrogenase activities and a significant elevation of liver endogenous ehtanol and a clear tendency to enhance blood acetaldehyde levels. Pyruvate increased blood endogenous acetaldehyde in CCl4-treated animals and endogenous ethanol--in the control group of animals. Threonine elevated endogenous acetaldehyde in normal rats. Phosphoethanolamine increased endogenous ethanol in the intact and CCl4 groups. At the same time, in CCl4-treated rats pyruvate administration increased the liver pyruvate dehydrogenase, threonine decreased threonine aldolase, whereas phosphoethanolamine decreased phosphoethanolamine lyase. Thus, the CCl4 effect on blood endogenous acetaldehyde and ethanol may be mediated through decreased liver ALDH and ADH activities. Liver injury promotes the accumulation of acetaldehyde, derived from physiological sources, including the degration of pyruvate and threonine by decreased acetaldehyde oxidation.

丙酮酸脱氢酶、苏氨酸醛缩酶和磷酸乙醇胺裂解酶在正常代谢过程中产生乙醛。我们研究了这些酶的底物(丙酮酸500 mg/kg, i.p.,索氨酸500 mg/kg, i.p.,磷酸乙醇胺230 mg/kg, i.p.)对正常大鼠和慢性四氯化碳(CCl4)引起的肝损伤大鼠(每只大鼠0.2 ml i.p.,每周2次,持续4周)血液中内源性乙醛和乙醇浓度以及肝脏中产生和氧化乙醛的酶活性的影响。在给药前和给药后30分钟和1小时分别采血。内源性乙醛和乙醇采用顶空气相色谱法测定。CCl4处理导致肝脏酒精脱氢酶和醛脱氢酶活性降低,肝脏内源性乙醇显著升高,血液乙醛水平明显升高。丙酮酸增加了ccl4处理动物的血液内源性乙醛和对照组动物的内源性乙醇。苏氨酸能提高正常大鼠体内的内源性乙醛。磷酸乙醇胺增加了完整组和CCl4组的内源性乙醇。同时,ccl4处理大鼠肝脏丙酮酸脱氢酶升高,苏氨酸降低苏氨酸醛缩酶,而磷酸乙醇胺降低磷酸乙醇胺裂解酶。因此,CCl4对血液内源性乙醛和乙醇的影响可能是通过降低肝脏ALDH和ADH活性来介导的。肝损伤促进来自生理来源的乙醛的积累,包括乙醛氧化减少对丙酮酸和苏氨酸的降解。
{"title":"[Effect of pyruvate, threonine, and phosphoethanolamine on acetaldehyde metabolism in rats with toxic liver injury].","authors":"P S Pron'ko,&nbsp;V I Satanovskaia,&nbsp;B I Gorenshteĭn,&nbsp;A B Kuz'mich,&nbsp;T N Pyzhik","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Pyruvate dehydrogenase, threonine aldolase and phosphoethanolamine lyase can produce acetaldehyde during normal metabolism. We studied the effect of loading with the substrates of these enzymes (pyruvate, 500 mg/kg, i.p., threonine 500 mg/kg, i.p., and phosphoethanolamine, 230 mg/kg, i.p.) on the blood concentrations of endogenous acetaldehyde and ethanol and the activities of enzymes producing and oxidizing acetaldehyde in the liver of normal rats and rats with liver injury provoked by chronic carbon tetrachloride (CCl4) treatment (0.2 ml i.p. per rat, 2 times a week during 4 weeks). Blood was collected before the treatment and then 30 min and 1 h following the administration of the substrates to intact and CCl4-treated rats. Endogenous acetaldehyde and ethanol were determined by headspace GC. The CCl4 treatment resulted in decreased liver alcohol dehydrogenase and aldehyde dehydrogenase activities and a significant elevation of liver endogenous ehtanol and a clear tendency to enhance blood acetaldehyde levels. Pyruvate increased blood endogenous acetaldehyde in CCl4-treated animals and endogenous ethanol--in the control group of animals. Threonine elevated endogenous acetaldehyde in normal rats. Phosphoethanolamine increased endogenous ethanol in the intact and CCl4 groups. At the same time, in CCl4-treated rats pyruvate administration increased the liver pyruvate dehydrogenase, threonine decreased threonine aldolase, whereas phosphoethanolamine decreased phosphoethanolamine lyase. Thus, the CCl4 effect on blood endogenous acetaldehyde and ethanol may be mediated through decreased liver ALDH and ADH activities. Liver injury promotes the accumulation of acetaldehyde, derived from physiological sources, including the degration of pyruvate and threonine by decreased acetaldehyde oxidation.</p>","PeriodicalId":23535,"journal":{"name":"Voprosy meditsinskoi khimii","volume":"48 3","pages":"278-85"},"PeriodicalIF":0.0,"publicationDate":"2002-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22000712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Voprosy meditsinskoi khimii
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1